EZH2 appears to be particularly important in high‐grade gliomas where Polycomb repressive complexes promote disease progression and therapy resistance by sustaining cancer cell self‐renewal and favouring cellular plasticity 24, 25, 26, 27, 28, 29. The gene discussed is EZH2; the disease is cancer.